Cargando…

Construction and experimental verification of user-friendly molecular subtypes mediated by immune-associated genes in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) accounts for third most cancer death globally, and its prognosis continues to be poor even with many novel therapeutic approaches emerging. The advent of immunotherapy seems to offer new hope, but low response rates are an unresolved problem. To gain further knoeledge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Juzheng, Wang, Yang, Wang, Xudan, Zhang, Wenjie, Ding, Rui, Yue, Shuqiang, Li, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391001/ https://www.ncbi.nlm.nih.gov/pubmed/35992798 http://dx.doi.org/10.3389/fonc.2022.924059

Ejemplares similares

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

Characteristic of molecular subtypes based on PANoptosis-related genes and experimental verification of hepatocellular carcinoma
por: Ren, Haitao, et al.
Publicado: (2023)

Identification and Verification of Immune Subtype-Related lncRNAs in Clear Cell Renal Cell Carcinoma
por: Wang, Zhifeng, et al.
Publicado: (2022)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

A Bionic Self-Assembly Hydrogel Constructed by Peptides With Favorable Biosecurity, Rapid Hemostasis and Antibacterial Property for Wound Healing
por: Wang, Yang, et al.
Publicado: (2022)

Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma
por: Zhu, Xiao-Ren, et al.
Publicado: (2022)

Necroptosis-Related Genes Signatures Identified Molecular Subtypes and Underlying Mechanisms in Hepatocellular Carcinoma
por: Wei, Jianguo, et al.
Publicado: (2022)

Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma
por: Wang, Baodong, et al.
Publicado: (2023)

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers
por: Meng, Chunliu, et al.
Publicado: (2022)

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023)

Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM)
por: Yang, Xiaobing, et al.
Publicado: (2023)

WIPI2 enhances the vulnerability of colorectal cancer cells to erastin via bioinformatics analysis and experimental verification
por: Yu, Liying, et al.
Publicado: (2023)

The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype
por: Yu, Jing-Jing, et al.
Publicado: (2021)

Construction and Verification of the Molecular Subtype and a Novel Prognostic Signature Based on Inflammatory Response-Related Genes in Uveal Melanoma
por: Zhang, Feng, et al.
Publicado: (2023)

Regulatory Mechanism and Experimental Verification of Patchouli Alcohol on Gastric Cancer Cell Based on Network Pharmacology
por: Song, Yanru, et al.
Publicado: (2021)

Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2021)

Prediction of bile duct injury after transarterial chemoembolization for hepatocellular carcinoma: Model establishment and verification
por: Guo, Jianxi, et al.
Publicado: (2022)

Construction and Verification of Immunohistochemistry Parameters-Based Classifier to Predict Local-Recurrence of Upper Tract Urothelial Carcinoma After Kidney-Sparing Surgery
por: Cheng, Xu, et al.
Publicado: (2022)

Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma
por: Chen, Xiaoyuan, et al.
Publicado: (2022)

High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification
por: Jiang, Xiaohong, et al.
Publicado: (2023)

A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes
por: Zhang, Qiyao, et al.
Publicado: (2020)

Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data
por: Ahmaderaghi, Baharak, et al.
Publicado: (2022)

Identification of endothelial-related molecular subtypes for bladder cancer patients
por: Li, Deng-xiong, et al.
Publicado: (2023)

Application of Nanoparticles in Diagnosis and Treatment of Pancreatic Cancer
por: Yuan, Juzheng, et al.
Publicado: (2022)

Construction of an M2 macrophage-related prognostic model in hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

The angiogenic genes predict prognosis and immune characteristics in esophageal squamous cell carcinoma: Evidence from multi-omics and experimental verification
por: Wang, Shuaiyuan, et al.
Publicado: (2022)

Immune subtype identification and multi-layer perceptron classifier construction for breast cancer
por: Yang, Xinbo, et al.
Publicado: (2022)

Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma
por: Cao, Weiwei, et al.
Publicado: (2021)

Construction and Verification of Risk Predicting Models to Evaluate the Possibility of Venous Thromboembolism After Robot-Assisted Radical Prostatectomy
por: Cheng, Xu, et al.
Publicado: (2022)

Breast Cancer Molecular Subtype Prediction on Pathological Images with Discriminative Patch Selection and Multi-Instance Learning
por: Liu, Hong, et al.
Publicado: (2022)

Exploration of the Potential Mechanism of Tao Hong Si Wu Decoction for the Treatment of Breast Cancer Based on Network Pharmacology and In Vitro Experimental Verification
por: Huang, Shi, et al.
Publicado: (2021)

Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology
por: Yang, Miaolun, et al.
Publicado: (2023)

Optimal Selection of Imaging Examination for Lymph Node Detection of Breast Cancer With Different Molecular Subtypes
por: Zheng, Mingjie, et al.
Publicado: (2022)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim–Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer
por: Hu, Shaopu, et al.
Publicado: (2022)

Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model
por: Zhang, Yanlong, et al.
Publicado: (2020)

Corona enhancement combined with microvascular invasion for prognosis prediction of macrotrabecular-massive hepatocellular carcinoma subtype
por: Yang, Lili, et al.
Publicado: (2023)

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

Features of the immunosuppressive tumor microenvironment in endometrial cancer based on molecular subtype
por: Zhang, Chong, et al.
Publicado: (2023)

Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma
por: Xiao, Jingjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4cprdaebn7njlt50fkgh2lsbv